The terms “semaglutide AND PCOS,” “tirzepatide AND PCOS,” “tirzepatide AND insulin resistance,” “GLP-1 receptor agonist AND reproductive disorders,” “GLP-1 receptor agonist AND PCOS,” and “retatrutide” were used. Here, GLP1R is linked to polycystic ovary syndrome.